𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Primary carcinoid tumor of testis. Immunohistochemical, ultrastructural, and DNA flow cytometric study of three cases with a review of the literature

✍ Scribed by Angel Zavala-Pompa; Jae Y. Ro; Adel El-Naggar; Nelson G. OrdóNtez; Mahul B. Amin; Pamela D. Pierce; Alberto G. Ayala


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
871 KB
Volume
72
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Primary intratesticular sarcoma: Immunoh
✍ Robert M. Washecka; Albert J. Mariani; Rosemary E. Zuna; Stacey A. Honda; Clayto 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 529 KB

## BACKGROUND. Fourteen cases of testicular sarcoma have been reported in the contemporary era. These included 7 cases of rhabdomyosarcoma, 2 spindle cell sarcoma, 2 osteosarcoma, 1 leiomyosarcoma, 1 fibrosarcoma, and 1 chondrosarcoma.

Leydig cell tumor of the testis: A cytoh
✍ Agnese Assi; Maria Sironi; Antonio Maria Bacchioni; Paolo Declich; Luigi Cozzi; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB 👁 2 views

We report a case of Leydig cell tumor of the testis in a young man, in whom preoperative diagnosis was achieved by fine-needle aspiration biopsy cytology. Cytology, histology, and ultrastructural examination showed diagnostic Reinke's crystals, both in nuclei and in cytoplasm. Immunohistochemistry d

Synchronous bilateral primary germ cell
✍ H. J. Hoekstra; D. M. Mehta; H. Schraffordt Koops 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB

Synchronous bilateral primary germ cell tumors of the testis are exceedingly rare. The most common synchronous testicular tumors are seminomas, followed by embryonal carcinomas, teratocarcinomas, and choriocarcinomas. In a series of 385 patients we found nine with bilateral primary germ cell tumors

Regression of metastatic carcinoid tumor
✍ Wey L. Leong; Janice L. Pasieka 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

## Abstract ## Background The antiproliferative effect of the somatostatin analogue, octreotide, on metastatic carcinoid tumors is poorly understood. Partial tumor regression seen radiogaphically has been reported with the use of octreotide therapy for neuroendocrine tumors. Complete regression of